Teladoc expands obesity, weight management capabilities

Teladoc Health announced expanded capabilities designed to help employers and health plans manage rising demand for anti-obesity medication such as glucagon-like peptide 1 agonists and support safe, sustainable weight loss and cardiometabolic health improvement for members. “This is a medical and wellness approach that differs from other weight loss approaches currently in the market. Clients can provide their populations with comprehensive and integrated clinical care, that also addresses wellbeing, mental health and social drivers of health in a personalized manner,” said Dr. Vidya Raman-Tangella, Teladoc Health Chief Medical Officer. “The program is designed to deliver person to person support alongside technology support in the form of digitally connected smart scales, digital meal planning tools and connectivity with wearables. The program is designed to deliver sustained results by addressing comorbidities and cultural preferences, while minimizing side effects and costs associated with medications.”